On April 29, 2014, GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), will announce on 7 May, 2014 its second quarter and half year financial results for the period ending 31 March, 2014. GW will also host a conference call the same day at 1:00 p.m. BST (8:00 a.m. EDT). Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) closed at $73.20 in last trading session. Yesterday share price of the company was traded in the range of $67.40 to $73.57. Company now has a market value of $1.08 billion. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) price to sales ratio in past twelve months was calculated as27.00 and price to cash ratio as 22.67.
Equities research analysts at Stifel Nicolaus raised their price objective on shares of Auspex Pharmaceuticals (NASDAQ:ASPX) from $38.00 to $39.00 in a research note issued to investors on Friday, AnalystRatings.Net reports. Stifel Nicolaus’ price target points to a potential upside of 26.79% from the company’s current price. Auspex Pharmaceuticals Inc (NASDAQ:ASPX) stock traded in the range of $20.97 – $24.60 and at the end of the day, it closed at $21.44. Average trading volume of the company is $ 153,975.
On Apr 17, 2014, Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) (“Skystar” or the “Company”), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, announced the following updates to its patent portfolio: China’s State Intellectual Property Office (SIPO) granted the Company; patents in application status for two new products; Additional two patents have application pending and review status with SIPO ;Patent for one product in development expired, but the Company retains. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) after opening at $5.05, moved down -3.12% to $4.96 on last trading day. Company’s 52 week range is $1.00 – $7.43.
Flexion Therapeutics Inc (NASDAQ:FLXN) announced that it will host a conference call and webcast to report its first quarter 2014 financial results on Thursday, May 8, 2014, at 4:30 p.m. ET. Flexion Therapeutics Inc (NASDAQ:FLXN) stock hit highest price at $12.50, beginning with a price of $12.50 and decreased -5.95% to the close at $11.85 with day range of $11.45 – $12.50. The total market capitalization of the stock is $97.32 billion.